FDA Drug Approval, N012541, DEPO-PROVERA
FDA Drug Approval, N012541, DEPO-PROVERA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 012541
Company: PFIZER
Drug Name: DEPO-PROVERA
Active Ingredients: MEDROXYPROGESTERONE ACETATE
Strength: 400MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/23/1960
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: PFIZER
Drug Name: DEPO-PROVERA
Active Ingredients: MEDROXYPROGESTERONE ACETATE
Strength: 400MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 09/23/1960
Marketing Status: Discontinued
Submission Classification: Type 5 - New Formulation or New Manufacturer
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details